SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-004092
Filing Date
2021-02-03
Accepted
2021-02-03 16:55:59
Documents
69
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q tyme-10q_20201231.htm 10-Q 1511495
2 EX-10.1 tyme-ex101_112.htm EX-10.1 216662
3 EX-10.2 tyme-ex102_111.htm EX-10.2 101350
4 EX-31.1 tyme-ex311_9.htm EX-31.1 12511
5 EX-31.2 tyme-ex312_7.htm EX-31.2 12508
6 EX-32.1 tyme-ex321_6.htm EX-32.1 8353
  Complete submission text file 0001564590-21-004092.txt   6364353

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tyme-20201231.xml EX-101.INS 1230887
8 XBRL TAXONOMY EXTENSION SCHEMA tyme-20201231.xsd EX-101.SCH 60988
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tyme-20201231_cal.xml EX-101.CAL 35212
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tyme-20201231_def.xml EX-101.DEF 188760
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tyme-20201231_lab.xml EX-101.LAB 395439
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tyme-20201231_pre.xml EX-101.PRE 314753
Mailing Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921
Business Address 1 PLUCKEMIN WAY - SUITE 103 BEDMINSTER NJ 07921 212-461-2315
TYME TECHNOLOGIES, INC. (Filer) CIK: 0001537917 (see all company filings)

IRS No.: 453864597 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38169 | Film No.: 21586949
SIC: 2834 Pharmaceutical Preparations